Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 171

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

WNT10B/β‐catenin signalling induces HMGA2 and proliferation in metastatic triple‐negative breast cancer

Open access
Wend, Peter, Runke, Stephanie, Wend, Korinna, Anchondo, Brenda, Yesayan, Maria, Jardon, Meghan, Hardie, Natalie, Loddenkemper, Christoph, Ulasov, Ilya, Lesniak, Maciej S., Wolsky, Rebecca, Bentolila, Laurent A., Grant, Stephen G., Elashoff, David, Lehr, Stephan, Latimer, Jean J., Bose, Shikha, Sattar, Husain, Krum, Susan A., Miranda‐Carboni, Gustavo A. · 2013 · EMBO Molecular Medicine

Abstract

Wnt/β‐catenin signalling has been suggested to be active in basal‐like breast cancer. However, in highly aggressive metastatic triple‐negative breast cancers (TNBC) the role of β‐catenin and the underlying mechanism(s) for the aggressiveness of TNBC remain unknown. We illustrate that WNT10B induces transcriptionally active β‐catenin in human TNBC and predicts survival‐outcome of patients with both TNBC and basal‐like tumours. We provide evidence that transgenic murine Wnt10b ‐driven tumours are devoid of ERα, PR and HER2 expression and can model human TNBC. Importantly, HMGA2 is specifically expressed during early stages of embryonic mammogenesis and absent when WNT10B expression is lost, suggesting a developmentally conserved mode of action. Mechanistically, ChIP analysis uncovered that WNT10B activates canonical β‐catenin signalling leading to up‐regulation of HMGA2. Treatment of mouse and human triple‐negative tumour cells with two Wnt/β‐catenin pathway modulators or siRNA to HMGA2 decreases HMGA2 levels and proliferation. We demonstrate that WNT10B has epistatic activity on HMGA2, which is necessary and sufficient for proliferation of TNBC cells. Furthermore, HMGA2 expression predicts relapse‐free‐survival and metastasis in TNBC patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/emmm.201201320

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 171

Metadata

Authors
Wend, P., Runke, S., Wend, K., Anchondo, B., Yesayan, M., Jardon, M., Hardie, N., Loddenkemper, C., Ulasov, I., Lesniak, M. S., Wolsky, R., Bentolila, L. A., Grant, S. G., Elashoff, D., Lehr, S., Latimer, J. J., Bose, S., Sattar, H., Krum, S. A., & Miranda‐Carboni, G. A.
Venue
EMBO Molecular Medicine
Published
2013-01-11
Volume
5
Issue
2
Pages
264-279
ISSN
  • 1757-4676 (ISSN-L)
  • 1757-4684
OpenAlex
W1880466029
Cited by
171
References
4
FWCI
6.59
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: WNT10B/β‐catenin signalling induces HMGA2 and proliferation in metastatic triple‐negative breast cancer. https://app.cochat.ai/papers/10.1002/emmm.201201320
The paper
Wend, P., Runke, S., Wend, K., Anchondo, B., Yesayan, M., Jardon, M., Hardie, N., Loddenkemper, C., Ulasov, I., Lesniak, M. S., Wolsky, R., Bentolila, L. A., Grant, S. G., Elashoff, D., Lehr, S., Latimer, J. J., Bose, S., Sattar, H., Krum, S. A., & Miranda‐Carboni, G. A. (2013). WNT10B/β‐catenin signalling induces HMGA2 and proliferation in metastatic triple‐negative breast cancer. EMBO Molecular Medicine. https://doi.org/10.1002/emmm.201201320

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.